Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Simoons

Showing results (131-140 of 338) with videos related to

Pageof 34
Sort By:
European Heart Journal|November 1, 1984
Ineligibility for predischarge exercise testing after myocardial infarction in the elderly: implications for prognosisJ W Deckers, P Fioretti, R W Brower, et al.
Cardiovascular Research|February 26, 2000
Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance ratesM J de Groot, K W Wodzig, M L Simoons, et al.
Journal of the American College of Cardiology|June 17, 1998
Unstable angina: good long-term outcome after a complicated early courseR T van Domburg, A J van Miltenburg-van Zijl, R J Veerhoek, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 1, 1986
[Prognosis of the uncomplicated first heart infarct in patients less than 60 years of age: a reason for heart catheterization?]J W Deckers, P Fioretti, R W Brower, et al.
The Canadian Journal of Cardiology|November 1, 1986
Improved prognosis during and after myocardial infarction: a plea for an integrated and stratified approachP G Hugenholtz, P Fioretti, M L Simoons, et al.
Pharmacoepidemiology and Drug Safety|May 10, 2002
Variability in abciximab (ReoPro) prescribing: evidence based or budget driven?J E F Zwart-van Rijkom, H G M Leufkens, M L Simoons, et al.
Circulation|November 16, 1999
Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary interventionE Boersma, K M Akkerhuis, P Théroux, et al.
Heart (British Cardiac Society)|February 17, 2001
Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasmaM J de Groot, A M Muijtjens, M L Simoons, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 14, 1990
[Early thrombolysis improves the long-term prognosis for patients with a heart infarct]J Vos, J G Tijssen, F Vermeer, et al.
European Heart Journal|December 3, 1999
Impact of smoking cessation and smoking interventions in patients with coronary heart diseaseT F van Berkel, H Boersma, J W Roos-Hesselink, et al.
Pageof 34

Showing results (131-140 of 338) with videos related to

Sort By:
Pageof 34
European Heart Journal|November 1, 1984
Ineligibility for predischarge exercise testing after myocardial infarction in the elderly: implications for prognosisJ W Deckers, P Fioretti, R W Brower, et al.
Cardiovascular Research|February 26, 2000
Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance ratesM J de Groot, K W Wodzig, M L Simoons, et al.
Journal of the American College of Cardiology|June 17, 1998
Unstable angina: good long-term outcome after a complicated early courseR T van Domburg, A J van Miltenburg-van Zijl, R J Veerhoek, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 1, 1986
[Prognosis of the uncomplicated first heart infarct in patients less than 60 years of age: a reason for heart catheterization?]J W Deckers, P Fioretti, R W Brower, et al.
The Canadian Journal of Cardiology|November 1, 1986
Improved prognosis during and after myocardial infarction: a plea for an integrated and stratified approachP G Hugenholtz, P Fioretti, M L Simoons, et al.
Pharmacoepidemiology and Drug Safety|May 10, 2002
Variability in abciximab (ReoPro) prescribing: evidence based or budget driven?J E F Zwart-van Rijkom, H G M Leufkens, M L Simoons, et al.
Circulation|November 16, 1999
Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary interventionE Boersma, K M Akkerhuis, P Théroux, et al.
Heart (British Cardiac Society)|February 17, 2001
Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasmaM J de Groot, A M Muijtjens, M L Simoons, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 14, 1990
[Early thrombolysis improves the long-term prognosis for patients with a heart infarct]J Vos, J G Tijssen, F Vermeer, et al.
European Heart Journal|December 3, 1999
Impact of smoking cessation and smoking interventions in patients with coronary heart diseaseT F van Berkel, H Boersma, J W Roos-Hesselink, et al.
Pageof 34